# Determination of perceived stress, salivary cortisol and interleukin-1β levels and clinical features of chronic urticaria in patients with dermographic urticaria in comparison to patients with chronic spontaneous urticaria and healthy individuals

**Authors:** Liborija Lugović-Mihić, Ina Novak-Hlebar, Dajana Smoljan, Ines Vukasović, Ema Barac, Maja Vilibić

PMC · DOI: 10.3389/fimmu.2026.1741412 · Frontiers in Immunology · 2026-02-12

## TL;DR

This study compares stress and immune markers in patients with dermographic urticaria, chronic spontaneous urticaria, and healthy individuals to understand the role of psychological stress in skin conditions.

## Contribution

The study provides new insights into the relationship between psychological stress and dermographic urticaria severity, suggesting potential benefits of psychological support.

## Key findings

- Perceived stress correlates with dermographism severity in SD/DU patients.
- Males have higher salivary cortisol and IL-1β levels than females.
- CSU patients show better disease control than SD/DU patients.

## Abstract

Although dermographic urticaria or symptomatic dermographism (SD), is the most common chronic inducible urticaria subtype, little is known about its etiopathogenesis and associated factors such as psychological stress.

In this cross-sectional study we included a total of 100 examinees, and compared the data/findings of 34 SD/DU patients to 33 chronic spontaneous urticaria (CSU) patients, and 33 healthy controls. We looked at perceived psychological stress (Perceived Stress Scale/PSS), salivary cortisol and IL-1β levels, clinical characteristics [dermographism activity/severity (on a scale from 1 to 4), disease control (Urticaria Control Test/UCT) and disease activity of CSU patients (Urticaria Activity Score/UAS)], and demographic data.

Dermographism activity/severity linearly correlated with perceived stress/PSS (r=0.347; p=0.045), with no correlation with other factors. Disease duration in SD/DU patients was negatively linearly related to salivary cortisol (r=-0.369; p=0.032), but not to IL-1β. In the SD/DU and CSU groups, no significant correlations were observed between salivary cortisol, IL-1β, PSS, and age; however, urticaria severity positively, linearly correlated with perceived stress (p=0.004). Males had higher salivary cortisol (median 1.1 vs. 0.9; p=0.028) and higher IL-1β levels than females (687.6 vs. 408.9 pg/mL; p=0.029), while females had higher perceived stress levels (16 vs. 12; p=0.006). CSU patients had significantly higher disease control than the SD/DU group (moderate effect size) (p=0.001). In SD/DU patients with concomitant allergies, lower cortisol values were recorded (moderate effect size) (median log 1.03 vs. 0.80 nmol/L; p=0.032) and disease lasted longer than in those with no allergies (a large effect size) (48 vs. 18 months; p=0.002). In SD/DU patients with associated conditions/diseases, their SD/DU lasted significantly longer than for those without comorbidities (60 vs. 24 months; p=0.017).

Since stress is often perceived by SD/DU patients and affects SD/DU activity/severity, psychological support could be beneficial for these patients.

## Linked entities

- **Diseases:** chronic urticaria (MONDO:0850230)

## Full-text entities

- **Genes:** IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}
- **Diseases:** oral allergy syndrome (MESH:D006967), infections (MESH:D007239), allergic rhinitis (MESH:D065631), dermatological, (MESH:D000168), pollinosis (MESH:D006255), DU (MESH:C536612), angioedema (MESH:D000799), rhinosinusitis (MESH:D000092562), fungal (MESH:D009181), atopic dermatitis (MESH:D003876), allergic (MESH:D004342), psychiatric disorder (MESH:D001523), Pulmonary and Allergic Diseases (MESH:D008171), malignancy (MESH:D009369), asthma (MESH:D001249), trauma (MESH:D014947), chronic inflammation (MESH:D007249), conditions (MESH:D020763), atopics (MESH:C566404), sleep disturbance (MESH:D012893), skin trauma (MESH:D012871), itch (MESH:D011537), urticarial (MESH:C535817), inflammatory or autoimmune disease (MESH:D001327), oral diseases (MESH:D009059), Urticaria (MESH:D014581), fatigue (MESH:D005221), CSU (MESH:D000080223), atopic diseases (MESH:D006969), allergic conjunctivitis (MESH:D003233)
- **Chemicals:** nicotine (MESH:D009538), FricTest (-), bilastine (MESH:C445659), montelukast (MESH:C093875), penicillin (MESH:D010406), alcohol (MESH:D000438), cetirizine (MESH:D017332), omalizumab (MESH:D000069444), loratadine (MESH:D017336), cortisol (MESH:D006854), histamine (MESH:D006632), desloratadine (MESH:C121345)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935963/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935963/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935963/full.md

---
Source: https://tomesphere.com/paper/PMC12935963